Russell Investments Group, Ltd. Cullinan Oncology, Inc. Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$15.63 - $29.35 $535,999 - $1.01 Million	34,293 New	34,293 $598,000
Q4 2023 Feb 05, 2024	BUY	$7.89 - $10.23 $18,147 - $23,529	2,300 New	2,300 $23,000
Q2 2023 Aug 10, 2023	BUY	$8.8 - $13.4 $172,462 - $262,613	19,598 Added 896.52%	21,784 $234,000
Q1 2023 May 09, 2023	BUY	$10.2 - $11.91 $22,297 - $26,035	2,186 New	2,186 $22,000

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.